(S)-Elobixibat

Overview

(S)-Elobixibat is the S enantiomer of Elobixibat ( HY-15790 ). (S)-Elobixibat is an orally effective Apical Sodium-Dependent Bile (IBAT) inhibitor. (S)-Elobixibat decreases LDL cholesterol , increases serum GLP-1 , promotes colon motility, and has the potential to study metabolic syndrome. (S)-Elobixibat can be used to study constipation, dyslipidemia, non-alcoholic hepatitis, and liver tumors.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Apical Sodium-Dependent Bile Acid Transporter | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-15790H
• CAS No.: 439087-68-0
• Molecular Formula: C36H45N3O7S2
• Molecular Weight: 695.89
• Purity: 99.98%
• Storage: RT, protect from light. In solvent -80°C, 1 year , -20°C, 6 months
• Availability: In-stock

Source

Original product source